170 related articles for article (PubMed ID: 7912495)
21. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
Nair S; Samy TS; Krishan A
Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
[TBL] [Abstract][Full Text] [Related]
22. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
Inaba M; Watanabe T; Sugiyama Y
Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
[TBL] [Abstract][Full Text] [Related]
24. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Ramu A; Glaubiger D; Fuks Z
Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
[TBL] [Abstract][Full Text] [Related]
25. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
Takenaga K; Tagawa M; Sakiyama S
Anticancer Res; 1996; 16(2):681-5. PubMed ID: 8687114
[TBL] [Abstract][Full Text] [Related]
27. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D; Wilberding C
Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
[TBL] [Abstract][Full Text] [Related]
28. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
29. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
Donenko FV; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
[TBL] [Abstract][Full Text] [Related]
30. Comparative cytotoxicities of a series of ellipticine and olivacine derivatives on multidrug resistant cells of human and murine origins.
Chevallier-Multon MC; Jacquemin-Sablon A; Besselièvre R; Husson HP; Le Pecq JB
Anticancer Drug Des; 1990 Nov; 5(4):319-35. PubMed ID: 1981310
[TBL] [Abstract][Full Text] [Related]
31. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
[TBL] [Abstract][Full Text] [Related]
32. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
33. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
Juvekar AS; Chitnis MP
Neoplasma; 1991; 38(2):207-11. PubMed ID: 2041579
[TBL] [Abstract][Full Text] [Related]
34. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
35. In vitro anti-multidrug resistance activities of acyclic and cyclic disulfonamides in murine leukemia cells.
Wakusawa S; Sawanishi H; Hayashi H
Anticancer Res; 1998; 18(4C):2961-5. PubMed ID: 9713492
[TBL] [Abstract][Full Text] [Related]
36. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
38. [Oncogene expression in adriamycin and platinum resistant cell lines].
Liu YB
Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):552-4, 576. PubMed ID: 7906188
[TBL] [Abstract][Full Text] [Related]
39. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
40. Influence of microenvironmental pH on adriamycin resistance.
Alabaster O; Woods T; Ortiz-Sanchez V; Jahangeer S
Cancer Res; 1989 Oct; 49(20):5638-43. PubMed ID: 2790781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
